🇺🇸 FDA
Pipeline program

rhTPO in combination with Rituximab

ITP-003

Phase 3 small_molecule completed

Quick answer

rhTPO in combination with Rituximab for Purpura is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Purpura
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials